Adding another product to its growing allergy franchise, Inspire Pharmaceuticals Inc. licensed U.S. and Canadian rights to bilastine, a late-stage oral antihistamine compound for allergic rhinitis, from Spanish pharmaceutical firm FAES Farma SA. (BioWorld Today) Read More
